Emergent BioSolutions Inc. — Director's Dealing 2021

May 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2021-05-25

Reporting Person: Zoon Kathryn C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-25	Common Stock	S	3139	$56.48	Disposed	14377	Direct

Footnotes

F1: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2021, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F3: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $56.11 to $56.86.